With comprehensive bioinformatics analysis of 3 big GC datasets, we currently screened out 37 genes that could predict poorer outcome of patients, and further identified that TIMP2 might play a key role in the prognosis of GC through directly binding with integrin and working on cell adhesion, EMT, and angiogenesis of cancers. Here, TIMP2 is linked to cancer.